Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicentre Cohort Study of Artificial Intelligence-based Methods for Pulmonary Nodule Segmentation, Benign-Malignant Risk Stratification, and Follow-up

NCT07815483 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT07815483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07815483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicentre Cohort Study of Artificial Intelligence-based Methods for Pulmonary Nodule Segmentation, Benign-Malignant Risk Stratification, and Follow-up
Lead sponsor
Shanghai East Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
October 31, 2029
Enrollment
16,880 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence (ai), lung neoplasms, pulmonary nodules